United Healthcare has released a detailed report - by FTI and Rubrum Consulting - on how its medical policies and evidence reviews stack up.
## ##
UnitedHealthcare Opens Its Medical Policy Process to Independent Review
A review of how coverage policies are made
UnitedHealth Group has released an independent review of UnitedHealthcare’s medical policy development process. Commissioned by the company and conducted by FTI Consulting and Rubrum Advising, the review examined how its medical policy team develops, approves, maintains, and revisits policies. UnitedHealth Group announced the findings on November 12, 2026. UnitedHealth Group
The reviewers assessed the team’s procedures against external standards and examined nine selected policies, spanning subjects from molecular testing for blood cancers to sleep apnea and cardiac monitoring. They described the development process as strong and evidence based. The team includes more than 80 staff members, and policies are reviewed at least annually. The nine sampled policies met the review’s criteria.
We present the findings as written. Readers of the reports should be aware of the chance that self-commissioned reports might skew favorable.
When appeals point back to the policy
One finding deserves attention beyond UnitedHealthcare. According to the full report, the medical policy team receives a monthly report on appeals and overturned decisions. It looks for patterns that may reflect a problem with a policy’s wording, its interpretation by reviewers, or a change in clinical evidence.
Those possibilities call for different responses. A sound coverage criterion may be stated so densely that clinicians struggle to follow it or reviewers apply it inconsistently; clearer language or education may resolve the problem. In another case, an appeal may expose new medical evidence that warrants reconsidering the criterion itself. The reviewers singled out this use of appeals data as a strength of UnitedHealthcare’s process.










